| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ... Autophagy 12 (1), 1-222, 2016 | 13372* | 2016 |
| A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci D Chang, MA Nalls, IB Hallgrímsdóttir, J Hunkapiller, M van der Brug, ... Nature genetics 49 (10), 1511, 2017 | 1122 | 2017 |
| The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy B Bingol, JS Tea, L Phu, M Reichelt, CE Bakalarski, Q Song, O Foreman, ... Nature, 2014 | 835 | 2014 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 422 | 2018 |
| Activity-dependent dynamics and sequestration of proteasomes in dendritic spines B Bingol, EM Schuman Nature 441 (7097), 1144-1148, 2006 | 382 | 2006 |
| USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria CN Cunningham, JM Baughman, L Phu, JS Tea, C Yu, M Coons, ... Nature cell biology 17 (2), 160, 2015 | 337 | 2015 |
| Autophosphorylated CaMKIIα acts as a scaffold to recruit proteasomes to dendritic spines B Bingol, CF Wang, D Arnott, D Cheng, J Peng, M Sheng Cell 140 (4), 567-578, 2010 | 314 | 2010 |
| Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease B Bingol, M Sheng Neuron 69 (1), 22-32, 2011 | 311 | 2011 |
| Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond B Bingol, M Sheng Free Radical Biology And Medicine 100, 210-222, 2016 | 290 | 2016 |
| Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs GN Patrick, B Bingol, HA Weld, EM Schuman Current biology 13 (23), 2073-2081, 2003 | 245 | 2003 |
| Synaptic protein degradation by the ubiquitin proteasome system B Bingol, EM Schuman Current opinion in neurobiology 15 (5), 536-541, 2005 | 153 | 2005 |
| Dynamic regulation of mitochondrial import by the ubiquitin system L Phu, CM Rose, JS Tea, CE Wall, E Verschueren, TK Cheung, ... Molecular cell 77 (5), 1107-1123. e10, 2020 | 110 | 2020 |
| Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross … T Simuni, L Uribe, HR Cho, C Caspell-Garcia, CS Coffey, A Siderowf, ... The Lancet Neurology 19 (1), 71-80, 2020 | 110 | 2020 |
| A proteasome-sensitive connection between PSD-95 and GluR1 endocytosis B Bingol, EM Schuman Neuropharmacology 47 (5), 755-763, 2004 | 109 | 2004 |
| Autophagy and lysosomal pathways in nervous system disorders B Bingol Molecular and Cellular Neuroscience 91, 167-208, 2018 | 35 | 2018 |
| Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients RN Alcalay, P Wolf, MSR Chiang, K Helesicova, XK Zhang, K Merchant, ... Annals of clinical and translational neurology 7 (10), 1816-1830, 2020 | 32 | 2020 |
| PTCD1 is required for mitochondrial oxidative-phosphorylation: possible genetic association with Alzheimer's disease D Fleck, L Phu, E Verschueren, T Hinkle, M Reichelt, T Bhangale, B Haley, ... Journal of Neuroscience 39 (24), 4636-4656, 2019 | 32 | 2019 |
| Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS S Dominguez, E Varfolomeev, R Brendza, K Stark, J Tea, J Imperio, ... Cell Death & Differentiation 28 (3), 915-931, 2021 | 28 | 2021 |
| PPEF2 opposes PINK1-mediated mitochondrial quality control by dephosphorylating ubiquitin CE Wall, CM Rose, M Adrian, YJ Zeng, DS Kirkpatrick, B Bingol Cell reports 29 (10), 3280-3292. e7, 2019 | 28 | 2019 |
| Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI) N Prakash, C Caspell-Garcia, C Coffey, A Siderowf, CM Tanner, ... Parkinsonism & related disorders, 2019 | 17 | 2019 |
